Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT05283564
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Percussive Ventilation Breathhold SABR (PVB-SABR) — OTHER
    Number of lung cancer patients with successful administration of PVB technique in PVB-SABR treatment

Study Details

The purpose of this research is to evaluate and determine the rate of successful administration of Percussive ventilation breathhold (PVB) to allow for more accurate radiotherapy for lung tumors.

Key Dates

Start date
Nov 2, 2022
Status verified
Jul 2025
Primary completion
May 4, 2026
Completion
Sep 4, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: Administration of Percussive ventilation breathhold (PVB) technique in healthy volunteers
    The healthy patient will execute the Percussive ventilation breathhold technique
  • Other: Administration of the PVB-SABR in lung cancer patients
    Lung cancer patients will execute a PV breathhold and a verification cone-beam CT scan.

Primary Outcome Measure

Rate of successful Percussive Ventilation Breathhold (PVB) maneuver in healthy volunteers. [ Time Frame: 18 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Cancer InstitutePalo AltoCalifornia94305
Kelly Huang
[email protected]
650-724-4606
Anoushka Kathiravan
[email protected]
650-725-4796
Wilson X Mai, MD,PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Palo Alto, CA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Stanford Cancer Institute· Palo Alto, CA

Related Studies